Report Detail
Global Radioisotope Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4690122 |
- 27 April, 2026 |
- Global |
- 94 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Radioisotope Therapy market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Radioisotope Therapy uses a radioactive drug that seeks out and destroys cancer cells while minimizing damage to neighboring healthy cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Radioisotope Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radioisotope Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Radioisotope Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Radioisotope Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Radioisotope Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radioisotope Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radioisotope Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Varian Medical Systems, Elekta, Hitachi Medical Corporation, IBA Worldwide, Accuray Incorporated, Advanced Accelerator Applications, Nordion Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Radioisotope Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
External Beam
Internal Beam
Market segment by Application
Thyroid Cancer
Bile Duct Cancer
Liver Cancer
Bone Metastases
Neuroblastoma
Others
Market segment by players, this report covers
Siemens Healthineers
GE Healthcare
Philips Healthcare
Varian Medical Systems
Elekta
Hitachi Medical Corporation
IBA Worldwide
Accuray Incorporated
Advanced Accelerator Applications
Nordion Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radioisotope Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioisotope Therapy, with revenue, gross margin, and global market share of Radioisotope Therapy from 2021 to 2026.
Chapter 3, the Radioisotope Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radioisotope Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioisotope Therapy.
Chapter 13, to describe Radioisotope Therapy research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Radioisotope Therapy by Type
- 1.3.1 Overview: Global Radioisotope Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Radioisotope Therapy Consumption Value Market Share by Type in 2025
- 1.3.3 External Beam
- 1.3.4 Internal Beam
- 1.4 Global Radioisotope Therapy Market by Application
- 1.4.1 Overview: Global Radioisotope Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Thyroid Cancer
- 1.4.3 Bile Duct Cancer
- 1.4.4 Liver Cancer
- 1.4.5 Bone Metastases
- 1.4.6 Neuroblastoma
- 1.4.7 Others
- 1.5 Global Radioisotope Therapy Market Size & Forecast
- 1.6 Global Radioisotope Therapy Market Size and Forecast by Region
- 1.6.1 Global Radioisotope Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Radioisotope Therapy Market Size by Region, (2021-2032)
- 1.6.3 North America Radioisotope Therapy Market Size and Prospect (2021-2032)
- 1.6.4 Europe Radioisotope Therapy Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Radioisotope Therapy Market Size and Prospect (2021-2032)
- 1.6.6 South America Radioisotope Therapy Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Radioisotope Therapy Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Siemens Healthineers
- 2.1.1 Siemens Healthineers Details
- 2.1.2 Siemens Healthineers Major Business
- 2.1.3 Siemens Healthineers Radioisotope Therapy Product and Solutions
- 2.1.4 Siemens Healthineers Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Siemens Healthineers Recent Developments and Future Plans
- 2.2 GE Healthcare
- 2.2.1 GE Healthcare Details
- 2.2.2 GE Healthcare Major Business
- 2.2.3 GE Healthcare Radioisotope Therapy Product and Solutions
- 2.2.4 GE Healthcare Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 GE Healthcare Recent Developments and Future Plans
- 2.3 Philips Healthcare
- 2.3.1 Philips Healthcare Details
- 2.3.2 Philips Healthcare Major Business
- 2.3.3 Philips Healthcare Radioisotope Therapy Product and Solutions
- 2.3.4 Philips Healthcare Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Philips Healthcare Recent Developments and Future Plans
- 2.4 Varian Medical Systems
- 2.4.1 Varian Medical Systems Details
- 2.4.2 Varian Medical Systems Major Business
- 2.4.3 Varian Medical Systems Radioisotope Therapy Product and Solutions
- 2.4.4 Varian Medical Systems Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Varian Medical Systems Recent Developments and Future Plans
- 2.5 Elekta
- 2.5.1 Elekta Details
- 2.5.2 Elekta Major Business
- 2.5.3 Elekta Radioisotope Therapy Product and Solutions
- 2.5.4 Elekta Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Elekta Recent Developments and Future Plans
- 2.6 Hitachi Medical Corporation
- 2.6.1 Hitachi Medical Corporation Details
- 2.6.2 Hitachi Medical Corporation Major Business
- 2.6.3 Hitachi Medical Corporation Radioisotope Therapy Product and Solutions
- 2.6.4 Hitachi Medical Corporation Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Hitachi Medical Corporation Recent Developments and Future Plans
- 2.7 IBA Worldwide
- 2.7.1 IBA Worldwide Details
- 2.7.2 IBA Worldwide Major Business
- 2.7.3 IBA Worldwide Radioisotope Therapy Product and Solutions
- 2.7.4 IBA Worldwide Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 IBA Worldwide Recent Developments and Future Plans
- 2.8 Accuray Incorporated
- 2.8.1 Accuray Incorporated Details
- 2.8.2 Accuray Incorporated Major Business
- 2.8.3 Accuray Incorporated Radioisotope Therapy Product and Solutions
- 2.8.4 Accuray Incorporated Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Accuray Incorporated Recent Developments and Future Plans
- 2.9 Advanced Accelerator Applications
- 2.9.1 Advanced Accelerator Applications Details
- 2.9.2 Advanced Accelerator Applications Major Business
- 2.9.3 Advanced Accelerator Applications Radioisotope Therapy Product and Solutions
- 2.9.4 Advanced Accelerator Applications Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Advanced Accelerator Applications Recent Developments and Future Plans
- 2.10 Nordion Inc.
- 2.10.1 Nordion Inc. Details
- 2.10.2 Nordion Inc. Major Business
- 2.10.3 Nordion Inc. Radioisotope Therapy Product and Solutions
- 2.10.4 Nordion Inc. Radioisotope Therapy Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Nordion Inc. Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Radioisotope Therapy Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Radioisotope Therapy by Company Revenue
- 3.2.2 Top 3 Radioisotope Therapy Players Market Share in 2025
- 3.2.3 Top 6 Radioisotope Therapy Players Market Share in 2025
- 3.3 Radioisotope Therapy Market: Overall Company Footprint Analysis
- 3.3.1 Radioisotope Therapy Market: Region Footprint
- 3.3.2 Radioisotope Therapy Market: Company Product Type Footprint
- 3.3.3 Radioisotope Therapy Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Radioisotope Therapy Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Radioisotope Therapy Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Radioisotope Therapy Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Radioisotope Therapy Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Radioisotope Therapy Consumption Value by Type (2021-2032)
- 6.2 North America Radioisotope Therapy Market Size by Application (2021-2032)
- 6.3 North America Radioisotope Therapy Market Size by Country
- 6.3.1 North America Radioisotope Therapy Consumption Value by Country (2021-2032)
- 6.3.2 United States Radioisotope Therapy Market Size and Forecast (2021-2032)
- 6.3.3 Canada Radioisotope Therapy Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Radioisotope Therapy Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Radioisotope Therapy Consumption Value by Type (2021-2032)
- 7.2 Europe Radioisotope Therapy Consumption Value by Application (2021-2032)
- 7.3 Europe Radioisotope Therapy Market Size by Country
- 7.3.1 Europe Radioisotope Therapy Consumption Value by Country (2021-2032)
- 7.3.2 Germany Radioisotope Therapy Market Size and Forecast (2021-2032)
- 7.3.3 France Radioisotope Therapy Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Radioisotope Therapy Market Size and Forecast (2021-2032)
- 7.3.5 Russia Radioisotope Therapy Market Size and Forecast (2021-2032)
- 7.3.6 Italy Radioisotope Therapy Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Radioisotope Therapy Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Radioisotope Therapy Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Radioisotope Therapy Market Size by Region
- 8.3.1 Asia-Pacific Radioisotope Therapy Consumption Value by Region (2021-2032)
- 8.3.2 China Radioisotope Therapy Market Size and Forecast (2021-2032)
- 8.3.3 Japan Radioisotope Therapy Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Radioisotope Therapy Market Size and Forecast (2021-2032)
- 8.3.5 India Radioisotope Therapy Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Radioisotope Therapy Market Size and Forecast (2021-2032)
- 8.3.7 Australia Radioisotope Therapy Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Radioisotope Therapy Consumption Value by Type (2021-2032)
- 9.2 South America Radioisotope Therapy Consumption Value by Application (2021-2032)
- 9.3 South America Radioisotope Therapy Market Size by Country
- 9.3.1 South America Radioisotope Therapy Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Radioisotope Therapy Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Radioisotope Therapy Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Radioisotope Therapy Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Radioisotope Therapy Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Radioisotope Therapy Market Size by Country
- 10.3.1 Middle East & Africa Radioisotope Therapy Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Radioisotope Therapy Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Radioisotope Therapy Market Size and Forecast (2021-2032)
- 10.3.4 UAE Radioisotope Therapy Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Radioisotope Therapy Market Drivers
- 11.2 Radioisotope Therapy Market Restraints
- 11.3 Radioisotope Therapy Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Radioisotope Therapy Industry Chain
- 12.2 Radioisotope Therapy Upstream Analysis
- 12.3 Radioisotope Therapy Midstream Analysis
- 12.4 Radioisotope Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Radioisotope Therapy. Industry analysis & Market Report on Radioisotope Therapy is a syndicated market report, published as Global Radioisotope Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Radioisotope Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
